PVI
SGNT

Pura Vida Investments’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Pura Vida Investments’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-89,713
Closed -$1.09M – 97
2016
Q1 		$1.09M Buy
+89,713
New +$1.26M 0.5% 56

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Pura Vida Investments's SGNT Position: Q2 2016 in Review

Pura Vida Investments sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 89,713 shares — an estimated $1.09M sold.

Pura Vida Investments first reported a position in SGNT in Q1 2016 and held it in 1 quarter. The position peaked at $1.09M in Q1 2016. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Pura Vida Investments reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Pura Vida Investments sold 89,713 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $1.09M.
  • Pura Vida Investments first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2016 and held it in 1 quarter.
  • Pura Vida Investments's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.09M in Q1 2016.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Pura Vida Investments's 13F filing for Q2 2016, filed 15 Aug 2016.